Senti Biosciences is trading at $0.27, up 5.84% versus the regular-session close, with the after-hours increase unexplained.

  • No verified company-specific announcement explaining the rise was found; available results showed no press-release page update newer than October 9.
  • Biotech shares faced pressure during the session, but that does not establish a reason for this move; no clear same-direction catalyst was identified.